Rosetta Genomics


Rosetta Genomics to raise $2 million in private stock sale

Rosetta Genomics (NASDAQ:ROSG) announced it is selling $1.9 million in securities in a private placement following a restructuring intended to reduce operating expenses announced earlier this week. The company is a developer and provider of microRNA-based molecular diagnostics and is headquartered in Rehovot, Israel with offices in Philadelphia. Earlier this week the company announced a […]